HIGH-DOSE CYCLOPHOSPHAMIDE AND HIGH-DOSE VP-16-213 FOR RECURRENT OR REFRACTORY SMALL-CELL LUNG-CANCER - A PHASE-II STUDY

被引：8
|
作者：
POSTMUS, PE
MULDER, NH
DEVRIESHOSPERS, HG
MULDER, POM
MAAS, A
MEINESZ, AF
SLEIJFER, DT
DEVRIES, EGE
机构：
[1] STATE UNIV GRONINGEN HOSP,DEPT MED ONCOL,9713 EZ GRONINGEN,NETHERLANDS
[2] STATE UNIV GRONINGEN HOSP,DEPT INTENS CARE MED,9713 EZ GRONINGEN,NETHERLANDS
[3] STATE UNIV GRONINGEN,DEPT MED MICROBIOL,9113 EZ GRONINGEN,NETHERLANDS
[4] RED CROSS BLOODBANK GRONINGEN DRENTHE,9713 EZ GRONINGEN,NETHERLANDS
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1985年 / 21卷 / 12期
关键词：
D O I：
10.1016/0277-5379(85)90239-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1467 / 1470
页数：4
相关论文
共 50 条
  • [21] PHARMACOKINETICS OF HIGH-DOSE ETOPOSIDE (VP-16-213) ADMINISTERED TO CANCER-PATIENTS
    HANDE, KR
    WEDLUND, PJ
    NOONE, RM
    WILKINSON, GR
    GRECO, FA
    WOLFF, SN
    CANCER RESEARCH, 1984, 44 (01) : 379 - 382
  • [22] PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN AND ETOPOSIDE IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    SMIT, EF
    PIERS, DA
    POSTMUS, PE
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (12) : 1965 - 1967
  • [23] HIGH-DOSE VP-16-213 AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR REFRACTORY MALIGNANCIES - A PHASE-I STUDY
    WOLFF, SN
    FER, MF
    MCKAY, CM
    HANDE, KR
    HAINSWORTH, JD
    GRECO, FA
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) : 701 - 705
  • [24] High-dose chemotherapy in small-cell lung cancer
    Pasini, F
    Durante, E
    De Manzoni, D
    Rosti, G
    Pelosi, G
    ANTICANCER RESEARCH, 2002, 22 (6B) : 3465 - 3472
  • [25] TREATMENT OF SMALL CELL LUNG-CANCER WITH VP-16, VINCRISTINE, ADRIAMYCIN, CYCLOPHOSPHAMIDE (EVAC), AND HIGH-DOSE RADIATION (XRT)
    GOODMAN, GE
    MCMAHON, LJ
    MANNING, MR
    SALMON, SE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 495 - 495
  • [26] PHASE-II STUDY OF HIGH-DOSE CIS-DICHLORODIAMMINEPLATINUM(II) IN THE TREATMENT OF NON-SMALL CELL LUNG-CANCER
    CASPER, ES
    GRALLA, RJ
    KELSEN, DP
    CVITKOVIC, E
    GOLBEY, RB
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2107 - 2109
  • [27] HIGH-DOSE CHLOROZOTOCIN IN LUNG-CANCER - A SOUTHWEST-ONCOLOGY-GROUP PHASE-II STUDY
    HAAS, CD
    STEPHENS, RL
    BUKOWSKI, RM
    STUCKEY, WJ
    MCCRACKEN, JD
    GAGLIANO, RG
    LEHANE, DE
    PUGH, RP
    CANCER TREATMENT REPORTS, 1983, 67 (7-8): : 705 - 707
  • [28] CHEMOTHERAPY WITH CISPLATINUM (CDDP) AND VP-16-213 IN SMALL-CELL LUNG-CANCER (SCLC)
    IYER, PR
    MORAN, EM
    KANESHIRO, CA
    CHEN, JJ
    OTTENHEIMER, EJ
    CLINICAL RESEARCH, 1987, 35 (03): : A524 - A524
  • [29] A PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN PLUS CISPLATINUM IN ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)
    MARTONI, A
    GUARALDI, M
    CASADIO, M
    BUSUTTI, L
    PANNUTI, F
    ANNALS OF ONCOLOGY, 1992, 3 (10) : 864 - 866
  • [30] NEGATIVE PHASE-II STUDY OF 5-FLUOROURACIL WITH HIGH-DOSE LEUCOVORIN IN NON-SMALL-CELL LUNG-CANCER
    OHE, Y
    SHINKAI, T
    EGUCHI, K
    SASAKI, Y
    TAMURA, T
    NAKAGAWA, K
    KOJIMA, A
    YAMADA, K
    OSHITA, F
    MIYA, T
    SAIJO, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1990, 20 (04) : 364 - 368
12345